glutamic acid has been researched along with cgp 7930 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marino, V; Ong, J; Parker, DA; Prager, RH; Puspawati, NM | 1 |
1 other study(ies) available for glutamic acid and cgp 7930
Article | Year |
---|---|
The CGP7930 analogue 2,6-di-tert-butyl-4-(3-hydroxy-2-spiropentylpropyl)-phenol (BSPP) potentiates baclofen action at GABA(B) autoreceptors.
Topics: Animals; Baclofen; Drug Evaluation, Preclinical; Drug Synergism; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Male; Morpholines; Neocortex; Organ Culture Techniques; Phenols; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Spiro Compounds; Tritium | 2008 |